Literature DB >> 19050311

The role of adaptive T cell immunity in atherosclerosis.

Ziad Mallat1, Soraya Taleb, Hafid Ait-Oufella, Alain Tedgui.   

Abstract

There is now solid evidence that T cell adaptive immunity is involved in atherogenesis. While initial studies have focused on the pathogenic arm of the immune response, more recent work clearly suggests an important role for several subsets of regulatory T cells in the protection against lesion development. Here, we review the current knowledge on the role of both pathogenic and regulatory adaptive T cell immunity in atherosclerosis, generated mainly from the study of mouse models of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 19050311      PMCID: PMC2674704          DOI: 10.1194/jlr.R800092-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  48 in total

Review 1.  The role of natural antibodies in atherogenesis.

Authors:  Christoph J Binder; Peter X Shaw; Mi-Kyung Chang; Agnès Boullier; Karsten Hartvigsen; Sohvi Hörkkö; Yury I Miller; Douglas A Woelkers; Maripat Corr; Joseph L Witztum
Journal:  J Lipid Res       Date:  2005-05-16       Impact factor: 5.922

2.  Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.

Authors:  Sabine Steffens; Fabienne Burger; Graziano Pelli; Yann Dean; Greg Elson; Marie Kosco-Vilbois; Lucienne Chatenoud; François Mach
Journal:  Circulation       Date:  2006-10-16       Impact factor: 29.690

3.  Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

Authors:  G H M van Puijvelde; A D Hauer; P de Vos; R van den Heuvel; M J C van Herwijnen; R van der Zee; W van Eden; T J C van Berkel; J Kuiper
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

4.  Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

Authors:  Israel Gotsman; Nir Grabie; Rajat Gupta; Rosa Dacosta; Malcolm MacConmara; James Lederer; Galina Sukhova; Joseph L Witztum; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

5.  T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.

Authors:  Chiara Buono; Christoph J Binder; George Stavrakis; Joseph L Witztum; Laurie H Glimcher; Andrew H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

6.  Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.

Authors:  Xinghua Zhou; Anna-Karin L Robertson; Charlotta Hjerpe; Göran K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-02       Impact factor: 8.311

7.  Protective role of interleukin-10 in atherosclerosis.

Authors:  Z Mallat; S Besnard; M Duriez; V Deleuze; F Emmanuel; M F Bureau; F Soubrier; B Esposito; H Duez; C Fievet; B Staels; N Duverger; D Scherman; A Tedgui
Journal:  Circ Res       Date:  1999-10-15       Impact factor: 17.367

Review 8.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

9.  Natural regulatory T cells control the development of atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Benoît L Salomon; Stéphane Potteaux; Anna-Karin L Robertson; Pierre Gourdy; Joffrey Zoll; Régine Merval; Bruno Esposito; José L Cohen; Sylvain Fisson; Richard A Flavell; Göran K Hansson; David Klatzmann; Alain Tedgui; Ziad Mallat
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

10.  Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis.

Authors:  Jenny Jongstra-Bilen; Mehran Haidari; Su-Ning Zhu; Mian Chen; Daipayan Guha; Myron I Cybulsky
Journal:  J Exp Med       Date:  2006-08-07       Impact factor: 14.307

View more
  79 in total

Review 1.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

2.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

3.  Ramping up RANTES in the acute response to arterial injury.

Authors:  Timothy Hla; Myat Lin Oo
Journal:  J Clin Invest       Date:  2009-12-28       Impact factor: 14.808

4.  L-selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis.

Authors:  Breanne N Gjurich; Parésa L Taghavie-Moghadam; Klaus Ley; Elena V Galkina
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 5.  Lymphocytes and the adventitial immune response in atherosclerosis.

Authors:  Kirsti A Campbell; Michael J Lipinski; Amanda C Doran; Marcus D Skaflen; Valentin Fuster; Coleen A McNamara
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

Review 6.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

Review 7.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

8.  Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Authors:  Dorette Raaz-Schrauder; Michael G Schrauder; Christian Stumpf; Piotr Lewczuk; Tobias Kilian; Barbara Dietel; Christoph D Garlichs; Christian Schlundt; Stephan Achenbach; Lutz Klinghammer
Journal:  Heart Vessels       Date:  2017-05-31       Impact factor: 2.037

9.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 10.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.